Literature DB >> 26323417

Ethical Considerations in Conducting Pediatric and Neonatal Research in Clinical Pharmacology.

Michelle Roth-Cline1, Robert M Nelson.   

Abstract

The critical need for pediatric research on drugs and biological products underscores the responsibility to ensure that children are enrolled in clinical research that is both scientifically necessary and ethically sound. In this chapter, we review key ethical considerations concerning the participation of children. We review a basic ethical framework to guide pediatric research, and suggest how this framework might be operationalized in linking science and ethics. Topics examined include: the status of children as a vulnerable population; the appropriate balance of risk and potential benefit in research; and parental permission and child assent to participate in research.

Entities:  

Mesh:

Year:  2015        PMID: 26323417     DOI: 10.2174/1381612821666150901105146

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

1.  Methodological and Ethical Issues in Pediatric Medication Safety Research.

Authors:  Delesha Carpenter; Daniel Gonzalez; George Retsch-Bogart; Betsy Sleath; Benjamin Wilfond
Journal:  Pediatrics       Date:  2017-08-04       Impact factor: 7.124

2.  Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies.

Authors:  Michelle Hume; Linda L Lewis; Robert M Nelson
Journal:  J Med Ethics       Date:  2017-05-15       Impact factor: 2.903

Review 3.  Phase 0/microdosing approaches: time for mainstream application in drug development?

Authors:  Tal Burt; Graeme Young; Wooin Lee; Hiroyuki Kusuhara; Oliver Langer; Malcolm Rowland; Yuichi Sugiyama
Journal:  Nat Rev Drug Discov       Date:  2020-09-08       Impact factor: 84.694

4.  Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective.

Authors:  Benjamin S Wilfond; Kathryn M Porter; Kate E Creevy; Matt Kaeberlein; Daniel Promislow
Journal:  Am J Bioeth       Date:  2018-10       Impact factor: 11.229

Review 5.  Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.

Authors:  T Burt; R J Noveck; D B MacLeod; A T Layton; M Rowland; G Lappin
Journal:  Clin Transl Sci       Date:  2017-04-18       Impact factor: 4.689

Review 6.  Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.

Authors:  T Burt; K Yoshida; G Lappin; L Vuong; C John; S N de Wildt; Y Sugiyama; M Rowland
Journal:  Clin Transl Sci       Date:  2016-03-30       Impact factor: 4.689

Review 7.  The Role of Master Protocols in Pediatric Drug Development.

Authors:  Robert M Nelson; Laurie S Conklin; Wendy J Komocsar; Fei Chen; Forrest Williamson; Wallace V Crandall
Journal:  Ther Innov Regul Sci       Date:  2022-09-01       Impact factor: 1.337

8.  Development of drugs for severe malaria in children.

Authors:  Phaik Yeong Cheah; Michael Parker; Arjen M Dondorp
Journal:  Int Health       Date:  2016-09-12       Impact factor: 2.473

9.  Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.

Authors:  Rachel G Greenberg; Amy Corneli; John Bradley; John Farley; Hasan S Jafri; Li Lin; Sumathi Nambiar; Gary J Noel; Chris Wheeler; Rosemary Tiernan; P Brian Smith; Jamie Roberts; Daniel K Benjamin
Journal:  Contemp Clin Trials Commun       Date:  2017-11-26

10.  Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.

Authors:  Rachel G Greenberg; Breck Gamel; Diane Bloom; John Bradley; Hasan S Jafri; Denise Hinton; Sumathi Nambiar; Chris Wheeler; Rosemary Tiernan; P Brian Smith; Jamie Roberts; Daniel K Benjamin
Journal:  Contemp Clin Trials Commun       Date:  2017-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.